Is GoodLife Health only for weight loss?

You already pay for your health in several places at once. A hormone clinic bills you every month. You order a private lab panel on your own because your annual physical has not included ApoB or Lipoprotein(a). The results sit in three portals, and nobody reads them side by side. Now a concierge practice has quoted you $20,000 a year to fix that, and before you sign you are looking at alternatives. On the GoodLife Health site, the first thing many people notice is GLP-1 medication, and a fair question follows: is this a weight-loss app with better design?

Is GoodLife Health only for weight loss? No. Weight medicine is one part of what the membership does, and whether it comes up at all depends on what a clinician finds. The clearest way to show the rest is to walk through the first three months of one patient, whom we will call Elena. Elena is a composite, assembled for this article from the kind of situation described above. She is not a real patient, and nothing in her story predicts what a clinician would find, prescribe or achieve for you.

Elena's situation: paying for care in pieces

Elena is perimenopausal. She sleeps worse than she used to, her energy dips in the afternoon, and her waistline has moved a little even though her habits have not. She started estradiol through a hormone platform last year. Our hormone pricing piece notes that menopause platforms and hormone clinics commonly charge $80 to $250 a month for bundled care, and that some add intake fees of $299 or more plus lab panels of $450 or more before treatment begins. Elena's clinic falls inside that range. It handles one hormone question competently and has never asked about her cholesterol.

Her primary care physician sees her once a year for a short visit, orders a standard panel, and tells her the numbers are in range. She buys a more detailed longevity panel on her own, reads it with a search engine, and keeps a list of questions nobody has answered: what her ApoB result means, whether her thyroid numbers explain the afternoon fatigue, and whether her hormone dose has anything to do with the change in her weight.

The concierge practice would put one physician in charge of all of it, and she does not doubt that it would be thorough. She is hesitating for two reasons. The first is the price. The second is that when she looked for a less expensive option built on the same idea, most of what she found were apps selling GLP-1 prescriptions in a few clicks. She does not want a pill mill. She wants a clinician who reads everything together and has no reason to prescribe more than she needs.

Her problem is fragmentation, and what she is really weighing is who will finally read the whole picture.

Why it looks like weight loss from the outside

Weight medicine is the loudest part of telehealth right now, so it is the first thing a visitor notices on almost any site in this field, including ours. GoodLife Health prescribes Wegovy, Zepbound, Mounjaro and Ozempic when a clinician judges them indicated, and we say so plainly. That is one of four areas the membership covers, and the model underneath is primary care.

GoodLife Health describes itself as precision direct primary care for Cardiometabolic Optimization. The order matters: diagnosis first, then treatment, then the long haul. The definitive guide sets out four clinical axes covered by one membership: metabolic (branded GLP-1 therapy, when indicated), endocrine (hormone and thyroid therapy, when indicated), diagnostic (quarterly Biomarker Audits) and the clinical relationship itself. The fourth axis carries the other three. The membership replaces the primary-care relationship and pairs with your insurance, which you keep for catastrophic coverage.

The reason these sit under one roof is biological. As the guide puts it, insulin resistance drives weight gain, visceral fat disrupts hormones, disrupted hormones stall metabolism, and stalled metabolism feeds vascular inflammation. Elena's three portals are describing one system. Her hormone question, her weight question and her ApoB question may turn out to be the same question asked three times, and a clinician who sees a third of the data can answer only a third of it.

The economics are the other half of the answer, and they speak directly to Elena's worry about pill mills. The guide notes that most telehealth platforms earn more when a patient is prescribed more, through margin on the molecule and upcharges as the dose rises. The GoodLife Health membership fee is the same whatever medication is indicated and whatever the dose, with no molecule upcharge and no dose upcharge. Medication is unbundled. When something is prescribed, it goes to the pharmacy the patient chooses, at that pharmacy's own price, and GoodLife Health sets nothing, sees nothing and takes nothing on it. A membership that earns nothing on the molecule has no reason to reach for one.

The same structure explains what we will not prescribe. Every medication is branded and FDA-approved, and there is no compounded GLP-1, ever. The FDA has published its concerns about unapproved GLP-1 drugs used for weight loss, the manufacturers have gone to court over compounded copies, and dosing and additive practices behind some of those products have been reported. Those are the facts we rely on, along with a simpler one: a clinician's license carries the responsibility for what is prescribed, and ours prescribe only FDA-approved medication.

Elena's first three months, step by step

Before month one: the check, the intake, the review

Elena begins with the eligibility check, then completes an intake covering her history, her current medications and what she wants from care. At checkout, $598 is charged, covering the first two months of the $299 membership. A clinician then reviews her intake, and not everyone is accepted. If the clinician cannot accept her into care, the $598 is refunded in full; once she is accepted, the first two months are non-refundable. Any medication billed later by a pharmacy follows that pharmacy's own return and refund policy.

Month one: the first Biomarker Audit

The first clinical step is a lab panel. For a patient like Elena, the first Biomarker Audit covers the full cardiometabolic picture, which the guide lists as ApoB, Lipoprotein(a), hs-CRP, HbA1c and insulin markers, lipids, and full hormone and thyroid panels. The hormone pricing piece spells out the hormone and thyroid side: TSH, free T3 and free T4, estradiol, progesterone, total and free testosterone, and DHEA-S, alongside metabolic markers.

Each group answers one of Elena's open questions. ApoB, Lipoprotein(a), hs-CRP and the lipid panel describe the vascular side of the system she has been reading about on her own. HbA1c and the insulin markers show how her body is handling blood sugar, which bears on the weight change she has noticed without any change in habits. The thyroid panel speaks to the fatigue. The sex hormones show where her current estradiol therapy actually stands, so the dose is judged on evidence as well as symptoms.

Every result goes into Elena's hands. She then has a video visit with her clinician to go through the panel as a whole, and between visits she can message the care team asynchronously with the questions that come up once she has read the numbers herself.

Month two: a protocol, or a reason to wait

What happens next depends on what the panel shows, which is why this section is written in conditionals.

If hormone therapy is indicated, Elena's clinician writes the protocol and sends the prescription to the pharmacy she chooses. The hormone pricing piece lists pharmacy pass-through prices of about $34 to $35 a month for estradiol tablets and about $37 to $44 a month for micronized progesterone. Whichever pharmacy she uses sets its own price, and none of that money passes through GoodLife Health. There is no separate hormone tier and no upgrade fee. If her thyroid numbers point to a problem, thyroid medication can be prescribed where indicated, on the same terms.

Elena's current clinic also prescribes a testosterone cream, and she asks whether that would continue. The honest answer is that it might not. Testosterone is a Schedule III controlled substance. It is prescribed and dispensed only where federal and state law allow, through our clinical partner's arrangement. The membership never promises it; the clinician decides.

If her insulin markers and weight point toward metabolic treatment, a branded GLP-1 is one option a clinician may consider, and only then. Self-pay prices are set by the manufacturers and pharmacies. As published in September 2026, NovoCare lists Wegovy pens at $199 a month for the first two fills, an introductory offer for new patients through December 2026, and $349 a month after. Whether her insurance covers any medication is between Elena, her plan and the pharmacy. Prior authorization is the pharmacy's process, and GoodLife Health does not run it or promise its outcome.

If the panel shows nothing that calls for a new prescription, the clinician says so. For a patient already paying for hormone care and outside labs, a clear reading of what does not need treatment is a useful result. The guide describes deprescribing, when the labs support it, as a success rather than a lost sale.

Month three: the second panel

Labs are quarterly, four cardiometabolic panels a year, so toward the end of the first quarter Elena's second Biomarker Audit is drawn. This is where the membership differs most from the single annual panel she has had until now. If something was started in month two, the second panel shows whether it is doing what it was meant to do. If nothing was started, the second panel confirms the baseline or shows a trend worth watching. The protocol is then held, adjusted or reduced on the evidence. After the first two months, the membership continues month to month at $299.

What it costs, and what it leaves out

The membership is $299 a month, month to month, with $598 charged at sign-up for the first two months. A full year is $3,588. The fee covers clinicians licensed in all fifty states, four cardiometabolic lab panels a year, every result in the patient's hands, asynchronous messaging with the care team, and video visits. The guide notes that comparable advanced panels retail for $250 to $500 each, and that the four annual audits alone retail for $1,000 to $2,000. The membership fee is generally eligible for HSA or FSA pre-tax dollars.

Some of what Elena buys today has no equivalent here, and she should know that before she switches. GoodLife Health does not offer research peptides, in-office procedures such as hormone pellets, or continuous glucose monitors as part of the model. If those are central to her plan, she would keep buying them elsewhere or choose a practice that provides them. The membership does not replace her health insurance; she keeps it for catastrophic coverage. It makes no promise of weight loss, of any particular result, or of any specific prescription.

Concierge practice or membership: an honest close

GoodLife Health sits between the $20,000-a-year concierge practice and the $99-a-month compounded app, and we would rather say that than blur it. Elena's choice, in full-year terms, is between the $20,000 she was quoted and the membership at $3,588 a year at its price as of October 2026, with any medication billed separately by her pharmacy.

What the concierge price buys beyond that is a question for the practice that quoted it, and Elena should ask it directly. Whatever she chooses, three questions sort the options: who reads every lab result, and how often are labs drawn; does anyone in the chain earn more when more is prescribed; and is the care built around a diagnosis or around a product?

Our answers are the ones in this piece. A clinician reads a cardiometabolic panel every quarter, nobody at GoodLife Health earns anything on medication, and the order is diagnosis first, then treatment, then the long haul. Whether that is enough for Elena depends on what else she wants from a practice, and only she can weigh that.

Who this is not for

If you want the cheapest, fastest route to a compounded semaglutide prescription, this is the wrong place, and the $99-a-month apps exist for that. If you want a guarantee that a specific drug will be prescribed, whether a GLP-1 or testosterone, the membership cannot give one; a clinician decides after reading your labs. If your plan centers on pellets, research peptides or continuous glucose monitoring, we do not provide them. If you hope to drop your insurance, the membership is no substitute for it. And if what you value most is a physician in an exam room near you, care here happens through video visits and messaging, so a local practice may suit you better.

For Elena, and for readers in her position, weight loss is one of the things the membership can treat when a clinician finds it indicated. The membership itself is a clinician reading the whole system every quarter.

Related Reading

• Bioidentical Hormone Therapy at Pharmacy Cost: The Real Numbers
• Cardiometabolic Optimization: The Definitive Guide

References

1. FDA's Concerns with Unapproved GLP-1 Drugs Used for Weight Loss (U.S. Food and Drug Administration). 2025. www.fda.gov/drugs/postmarket-drug-safety-information-patients-and-providers/fdas-concerns-unapproved-glp-1-drugs-used-weight-loss
2. NovoCare Pharmacy — Wegovy self-pay pricing (Novo Nordisk). 2026. www.novocare.com/pharmacy/wegovy.html